Moderna Seeks Full FDA Approval for Its Covid-19 Vaccine (2)

June 1, 2021, 12:40 PM

Moderna Inc. said it is seeking a full approval for its Covid-19 vaccine, a move that could make a shot cleared on an emergency basis during the pandemic into a stable source of revenue for years to come.

The company said in a statement Tuesday that it will submit data to the Food and Drug Administration on a rolling basis in coming weeks to support the application for use of the vaccine in people 18 and older.

Moderna’s shot, which like rival Pfizer Inc.’s is based on messenger RNA technology, has been shown to be highly effective in preventing ...

To read the full article log in.

Learn more about a Bloomberg Law subscription.